Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Veys

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Molecular Cancer Therapeutics|October 17, 2006
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancerLissandra Dal Lago, Virginie Durbecq, Christine Desmedt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Polysomy 17 in HER-2/neu status elaboration in breast cancer: effect on daily practiceYan Ma, Laurence Lespagnard, Virginie Durbecq, et al.
American Journal of Surgery|March 3, 2009
Eighteen months clinical experience with the GeneSearch breast lymph node assayIsabelle Veys, Virginie Durbecq, Samira Majjaj, et al.
Breast Cancer Research : BCR|November 24, 2022
Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registryCatherine Philippson, Samuel Larsen, Stéphane Simon, et al.
JCO Precision Oncology|September 28, 2022
Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease RelapseFrédéric Cailleux, Elisa Agostinetto, Matteo Lambertini, et al.
Oncoimmunology|February 16, 2017
Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancerLaurence Buisseret, Soizic Garaud, Alexandre de Wind, et al.
Plos One|January 26, 2011
HER2-positive circulating tumor cells in breast cancerMichail Ignatiadis, Françoise Rothé, Carole Chaboteaux, et al.
JCI Insight|August 14, 2019
Tumor infiltrating B-cells signal functional humoral immune responses in breast cancerSoizic Garaud, Laurence Buisseret, Cinzia Solinas, et al.
Future Oncology (London, England)|June 13, 2022
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breastElisa Agostinetto, Guilherme Nader-Marta, Marianne Paesmans, et al.
JAMA Oncology|December 4, 2015
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer RecurrenceMichail Ignatiadis, Hatem A Azim, Christine Desmedt, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|October 17, 2006
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancerLissandra Dal Lago, Virginie Durbecq, Christine Desmedt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Polysomy 17 in HER-2/neu status elaboration in breast cancer: effect on daily practiceYan Ma, Laurence Lespagnard, Virginie Durbecq, et al.
American Journal of Surgery|March 3, 2009
Eighteen months clinical experience with the GeneSearch breast lymph node assayIsabelle Veys, Virginie Durbecq, Samira Majjaj, et al.
Breast Cancer Research : BCR|November 24, 2022
Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registryCatherine Philippson, Samuel Larsen, Stéphane Simon, et al.
JCO Precision Oncology|September 28, 2022
Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease RelapseFrédéric Cailleux, Elisa Agostinetto, Matteo Lambertini, et al.
Oncoimmunology|February 16, 2017
Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancerLaurence Buisseret, Soizic Garaud, Alexandre de Wind, et al.
Plos One|January 26, 2011
HER2-positive circulating tumor cells in breast cancerMichail Ignatiadis, Françoise Rothé, Carole Chaboteaux, et al.
JCI Insight|August 14, 2019
Tumor infiltrating B-cells signal functional humoral immune responses in breast cancerSoizic Garaud, Laurence Buisseret, Cinzia Solinas, et al.
Future Oncology (London, England)|June 13, 2022
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breastElisa Agostinetto, Guilherme Nader-Marta, Marianne Paesmans, et al.
JAMA Oncology|December 4, 2015
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer RecurrenceMichail Ignatiadis, Hatem A Azim, Christine Desmedt, et al.
Pageof 5